Skip to main content

Reports

Search reports, investigative results, and agency plansShowing 1 - 10 of 180 results

Keyword

X

Date Range

Department of Education OIG

Review of State Plans for Use of Governor’s Emergency Education Relief Funds

The objectives of our review are to (1) review states’ initial 45-day GEER Fund reports to determine how states plan to allocate funds to entities within the three authorized categories: (a) local educational agencies, (b) institutions of higher education, and (c) education-related entities, and the criteria upon which these decisions were based; and (2) review GEER Fund annual reports to identify changes to and progress made from the initial plans in the 45-day reports.
Department of Justice OIG

Audit of the Criminal Division's and the Executive Office of the U.S. Attorneys' Management and Coordination of Pandemic-related Fraud Allegations and Referrals

The Office of the Inspector General initiated an audit to examine the Criminal Division's and the Executive Office of the U.S. Attorneys' management and coordination of pandemic-related fraud allegations and referrals.
Department of Health and Human Services OIG

Use of States' Immunization Information Systems To Monitor COVID-19 Vaccinations

Immunization Information Systems (IISs) play an integral role in monitoring vaccine uptake in the population and meeting vaccination goals. While the Centers for Disease Control and Prevention (CDC) and other stakeholders have long invested significant efforts to establish plans and standards to guide improvements in IISs, State, and local jurisdictions have often struggled to make these improvements. CDC's work to collect and share data on COVID-19 vaccinations relies heavily on State and local IISs working with Federal systems, but the preexisting limitations of these systems pose challenges for CDC's goal of comprehensive immunization data being made available for clinical and public health uses. This study will examine State and Federal experiences using these systems to collect, share, and monitor data on COVID-19 vaccinations, and identify lessons learned that can improve vaccination data and monitoring for future mass vaccination campaigns as well as routine vaccination programs.
Department of Health and Human Services OIG

Audit of Health Resources and Services Administration's COVID-19 Supplemental Grant Funding for Health Centers

The Health Resources and Services Administration (HRSA) awarded nearly $2 billion in supplemental grant funding to 1,387 health centers nationwide in fiscal year (FY) 2020 to respond to the COVID-19 public health emergency. The funding was intended to support the health centers' activities related to the detection, prevention, diagnosis, and treatment of COVID-19, including maintaining or increasing health center capacity and staffing levels during the pandemic, and expanding COVID-19 testing. The performance period for each of these one-time supplemental grant awards, which HRSA began awarding in March 2020, is 12 months. Health centers were permitted to charge to their awards pre-award costs in order to support expenses related to the COVID-19 public health emergency dating back to January 20, 2020. We will determine whether health centers used their HRSA COVID-19 supplemental grant funding in accordance with Federal requirements and grant terms.
Small Business Administration OIG

The COVID-19 Assistance Information Systems Security Controls

The Office of Inspector General, Audits Division will conduct an evaluation of the COVID-19 assistance information systems security controls.  Our objective is to determine what internal controls the organization designed to address third-party contractor system cybersecurity risks caused by COVID-related economic relief transactions.
Small Business Administration OIG

Inspection of SBA’s Implementation of the Shuttered Venues Operators Grants Program

The Office of Inspector General Audits Division will conduct an inspection of SBA’s implementation of the Shuttered Venues Operators Grants Program. Our objective is to assess whether SBA implemented the Shuttered Venues Operators Grant program with sufficient controls to ensure applicant compliance with the eligibility requirements in the Economic Aid to Hard-Hit Small Businesses, Nonprofits, and Venues Act.
Small Business Administration OIG

SBA’s Handling of Potentially Fraudulent Paycheck Protection Program Loans

Inspection Notification: SBA’s Handling of Potentially Fraudulent Paycheck Protection Program Loans
Treasury Inspector General for Tax Administration

Health and Safety Unannounced Site Visits

The objective of the evaluation is to assess the IRS’s efforts to protect the health and safety of its employees physically present during the COVID-19 pandemic.
Department of Health and Human Services OIG

Audit of Indian Health Service's COVID-19 Vaccine Policies and Procedures for COVID-19 Vaccines Distributed to Tribal Health Programs

The COVID-19 pandemic has disproportionately affected American Indian and Alaska Native (AI/AN) populations nationwide.  We will focus on IHS's coordination of the distribution, allocation, and administration of the vaccine to Tribal Health Programs. The objective of this audit is to determine whether IHS followed the Memorandum of Agreement for the CDC COVID-19 Federal Agency Vaccination Program and the IHS COVID-19 Pandemic Vaccine Plan to coordinate the distribution, allocation, and administration of the vaccines to Tribal Health Programs to protect AI/AN beneficiaries. 
Department of Health and Human Services OIG

Yearend Review of Opioid Use in Medicare Part D in 2020

Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020.